UV Curable Inks Market Data Shows Promising Growth Owing To Growing Demand In Multiple Printing Applications

The global UV Curable Inks Market is expected to reach USD 5.13 billion by 2024, according to a new report by Grand View Research, Inc. Ultraviolet curable inks are increasingly substituting various solvent-based inks in automotive, packaging and publishing applications owing to low environmental impact and high performance efficiency.

uv-curable-inks-market.png

Technological innovations related to the use of UV LED systems to enable curing of inks are expected to enhance quality, which in turn is expected to propel demand over the forecast period. Additionally, efficient air-cooling techniques have also lowered the amount of technological infrastructure and equipment required to support the curing process, thus saving energy and improving cost efficiency.

Growing demand for inks in printing application is expected to be the key driver for UV curable ink market over the forecast period. Furthermore, faster drying times coupled with high saturation properties of the product enables use over rigid surfaces, thus promoting application in printing. However, the high cost of the product as compared to its counterparts is likely to restrain market growth over the next eight years.

Browse Full Research Report on UV Curable Inks Market: http://www.grandviewresearch.com/industry-analysis/uv-curable-inks-market

Further key findings from the report suggest:

  • Free radical UV curable inks accounted for over 90% of the revenue share in 2015.High flexibility coupled with increased depth of cure and low cost are expected to drive demand over the next eight years. However, the growth is limited by the emergence of cationic technology providing improved adhesion properties as compared to free radical inks.
  • Publication application of ultraviolet curable inks accounted for the largest revenue share in 2015, and this trend is expected to continue over the forecast period owing to rising need for environment-friendly ink in this sector. However, growing electronic content replacing publication printing is likely to limit growth over the forecast period.
  • Packaging industry application in the market is expected to witness the fastest growth, at a CAGR of over 12% from 2016 to 2024. Growing demand for low migration UV cured inks in food& beverage as well as other consumer goods packaging is likely to augment growth over the projected period. Furthermore, stringent regulations restricting the use solvent based inks in packaging application owing to its VOC content is expected to promote demand for UV curable inks.
  • Asia Pacific accounted for the largest revenue share, of over 50% in 2015. The region is also expected to witness the highest growth, owing to rising demand for publication and packaging. Furthermore, rising demand for medical device manufacturing technology is expected to augment growth over the forecast period.
  • Key players in the industry include Hewlett & Packard Company, RUCO Druckfarben,Toyo Ink SC Holdings Co., Ltd., T&K Toka Corporation, NUtec Ink, Marabu Co., Mimaki Global, Superior Printing Inks, Armstrong World Industries Inc., Heraeus Noblelight, Bordeaux Digital Printink, Roland DGA, Changzhou Dobest International Trading Co. Ltd.

Read Our Blog: http://www.grandviewresearch.com/blogs/bulk-chemicals

Grand View Research has segmented the UV curable inks market on the basis of product, application and region:

UV Curable Inks Market Product Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 – 2024)

  • Free Radical
  • Cationic

UV Curable Inks Market Application Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 – 2024)

  • Automotive
  • Medical
  • Publications
  • Packaging
  • Others

UV Curable Inks Market Regional Outlook (Volume, Kilo Tons; Revenue, USD Million, 2013 – 2024)

  • North America
    • US.
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • Middle East & Africa

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-uv-ultraviolet-curable-inks-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Automated Microscopic Urine Analyzers are the Next Generation & advanced instruments are awaited to foster the Urinalysis Market Growth

The Global Urinalysis Market is expected to reach over USD 2.14 billion by 2022, according to a new report by Grand View Research, Inc.

Automation is a key technological advancement affecting the efficiency and accuracy delivered by the new generation urinalysis devices and hence, the persistent demand for novel urinalysis instruments and consumables. For instance, the automatic bench-top and portable biochemical urine analyzers, automated urine sediment analyzers (Aution Hybrid AU-4050 from Arkray),and automated microscopic urine analyzers (Sysmex UF-1000i) are the next generation, advanced instruments is anticipated to foster the urinalysis market growth.

urinalysis-market.png

The introduction of CLIA-waived urine reagent strips such as CLIA-URS-10, CLIA-URS-10-3PROMO, and CLIA-URS-10-10 provide for an effective screening tool for rapid testing in urine analysis which are estimated to enhance the usage rates of urinalysis reagents thus accentuating the market growth over the forecast period.

The target population base for urinalysis market is increasing owing to, factors such as the rising prevalence of target diseases, misdiagnosis, and low awareness levels pertaining to urine analysis in low-income countries. High incidences of obesity coupled with hypertension, diabetes, and other chronic disorders foster the growth of the urinalysis market.

Browse Full Research Report on Urinalysis Market: http://www.grandviewresearch.com/industry-analysis/urinalysis-market

Further key findings from the study suggest:

  • Urinary Tract Infections (UTIs)dominated the application segment in 2014. The foremost factor responsible for its high share is the rising prevalence of UTIs, especially in females. However, diabetes is estimated to be the fastest growing application segment with a CAGR of over 10% during the forecast period owing to a surge in the demand for automated and user-friendly urinalysis products for long-term diabetes management.
  • Consumables held the largest share with revenue generation of over USD 1 million in 2014. The increasing usage of test strips and reagents for urinalysisis one of the major factors that are attributed to its large market share. However, the instrument segment is expected to witness the fastest growth with a CAGR of over 7%. Automation of instruments with improved efficiency and reliability is expected to govern this segment’s growth.
  • The home healthcare segment, on the other hand, is anticipated to grow at a substantial rate over 7.5%. The availability of technologically enabled point-of-care urinalysis systems, such as CLINITEK Status, is a key factor expected to reinforce the market growth.
  • North America dominated the overall urinalysis market with a revenue generation of over USD 540 million in 2014. The introduction of advanced urine analyzers by key market players in the U.S., favorable government initiatives ensuring the betterment of healthcare testing, and the high amount of healthcare spending in this region are the key factors attributing to the largest market share of this region.
  • Key players of this market include Roche Diagnostics, Alere, Inc., Siemens Healthcare, Bio-Rad, ARKRAY, Inc., Mindray, and Sysmex.
  • Market participants are constantly engaged in the introduction of novel diagnostic products in an attempt to ensure their sustainability and increase the penetration of their product portfolio. For instance, in June 2014, Roche launched a fully automated urine testing analyzer named Cobas 6500 with an objective to enhance staff safety and increase the result reliability.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global urinalysis market on the basis of product, application, end-use, and region:

Global Urinalysis Product Outlook (Revenue, USD Million, 2015 – 2022)

  • Instruments
    • Biochemical urine analyzers
      • Automated biochemical analyzers
      • Semi-automated biochemical analyzers
    • Automated urine sediment analyzers
      • Microscopic urine analyzers
      • Flow-cytometric urine analyzers
    • Consumables
      • Dipsticks
      • Reagents
      • Disposables

Global Urinalysis Application Outlook (Revenue, USD Million, 2015 – 2022)

  • UTIs
  • Diabetes
  • Kidney Disease
  • Hypertension
  • Liver disease
  • Others

Global Urinalysis End-use Outlook (Revenue, USD Million, 2015 – 2022)

  • Hospitals
  • Clinical Laboratories
  • Home healthcare
  • Research and academics
  • Others

Urinalysis Regional Outlook (Revenue, USD Million, 2015 – 2022)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

Access Press Release of this Report:  http://www.grandviewresearch.com/press-release/global-urinalysis-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Asia-Pacific to Maintain Strong Grip on Vaccine Market Up To 2024

The global Vaccine Market is expected to reach over USD 77.5 billion by 2024, according to a new report by Grand View Research, Inc. The presence of numerous molecules in the pipeline is anticipated to meet the demand for efficient vaccines. These include vaccines for chest infection, tuberculosis, malaria, and dengue. Most of the key players are actively leveraging on their vaccine development technologies to launch novel preventative solutions with an objective to increase their market share. For instance, Pfizer, Inc. is involved in the development of vaccines to prevent severe infections caused by Meningococcal B, Clostridium difficile, and Staphylococcus aureus.

vaccine-market.png

Furthermore, the broad coalition of governments, worldwide, working to promote the awareness of vaccination benefits through immunization programs with the objective of containing the propagation of communicable diseases that are associated with high morbidity and mortality is expected to stimulate the market growth.

For instance, the ‘Immunize Australia Program’ sponsors the immunization of individuals, which acts as a preventative action in preventing disease occurrence and checks rampant disease transmission thus protecting millions of Australians from severe diseases. Another program that has been involved in achieving extensive immunization coverage on the Indian continent is the National Immunization Program, a government program that has focused on taking strong preventive measures to offset vaccine-preventable diseases, particularly in children.  

Browse Full Research Report on Vaccine Market: http://www.grandviewresearch.com/industry-analysis/vaccine-market

Further key findings from the study suggest:

  • The inactivated vaccine type segment was estimated to have over 14.5% market share in 2015 owing to the related advantages including easy storage and transport due to the highly stable nature of these vaccines. In December 2015, Sanofi Pasteur, Inc. launched a new trivalent, inactivated polio vaccine in India.
  • The DNA vaccine segment is presumed to be the fastest growing type over the forecast period owing to the ease of production compared to the cell-based vaccines and the promising, targeted immunization outcomes coupled with the continual developments in the biotechnology area. Other advantages associated are ease of production, long lasting immunogenicity, and no risk of reversion.
  • The cancer application segment is expected to witness the fastest growth with a CAGR of over 11.8% in the vaccinations market majorly attributable to the need for immunization against cancer coupled with the increasing prevalence of various types of cancer, such as cervical and colorectal cancers.
  • North America dominated the market in terms of revenue with over USD 12 billion in 2015, due mainly to the presence of extensive research and development activities and the existence of key participants of the industry in this region
  • Asia Pacific is identified to witness a lucrative growth with a CAGR of around 10.7% during the forecast period due to the growing population base and the increasing economic growth of countries, such as China, Japan, and India. Moreover, the availability of skilled labors at a lower cost and the low manufacturing operations cost provide a platform for clinical trial outsourcing of the vaccinations under development to expedite commercialization.
  • Leading players in this industry, among others are, Merck & Co., Inc., Emergent BioSolutions, Inc., Johnson and Johnson, Sanofi Pasteur, Inc., Pfizer, Inc., Novartis AG, CSL Ltd., and GlaxoSmithKline Plc. Other prominent players include Abbott Laboratories, Inc., AstraZeneca plc, Janssen Pharmaceuticals, Inc., Takeda Pharmaceuticals Company Ltd., and Valeant Pharmaceuticals International, Inc.
  • In April 2016, VBI vaccines, Inc. entered into a collaborative agreement with Sanofi Pasteur, Inc. to employ its “Lipid Particle Vaccine” formulation technology to better the stability of the Sanofi vaccines.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the global vaccines market on the basis of type, application, and region:

Global Vaccines Market By Type (Revenue, USD Million, 2013 – 2024)

  • Inactivated vaccines
  • DNA vaccines
  • Attenuated vaccines
  • Subunit vaccines
  • Conjugate vaccines
  • Toxoid vaccines
  • Others

Global Vaccines Market By Application (Revenue, USD Million, 2013 – 2024)

  • Infectious diseases
  • Cancer
  • Autism
  • Allergy
  • Others

Vaccines Market By Region (Revenue, USD Million, 2013 – 2024)

  • North America
    • US.
    • Canada
  • Europe
    • UK
    • Germany
  • Asia Pacific
    • Japan
    • China
  • Latin America
    • Brazil
  • MEA
    • South Africa

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-vaccine-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Vascular Closure Devices Market: Increasing Demand For Rapid And Specific Rise In Vascular Procedures

The Global vascular closure devices (VCDs) Market is anticipated to reach USD 1.3 billion by 2024, according to a new report by Grand View Research, Inc. Growing popularity of femoral artery cardiac catheterization and high success rate of VCDs for improved patient comfort and shortening of hemostasis time are potential factors for the projected growth of VCDs market over the forecast period. Adoption of VCDs for diagnostic and therapeutic interventions that facilitate endovascular image-guided interventions to detect coronary heart disease are expected to contribute toward the growth of this market throughout the forecast period.

vascular-closure-device-vcd-market.png

Moreover, ability of VCDs to overcome complications, such as prolonged bed rest and patient discomfort caused by manual compression, is expected to revolutionize the market growth over the forecast period.

Browse Full Research Report on Vascular Closure Devices Market: http://www.grandviewresearch.com/industry-analysis/vascular-closure-device-vcd-market

Further Key Findings from the Study Suggest:

  • VCDs offer three types of products, which includes active approximators, passive approximators, and external hemostatic devices. Out of all three, active approximators dominated the market in 2015 as they shorten the time to ambulation and possess high efficiency rate.
  • Amongst the different end-users of VCDs, acute care facilities accounted for the largest share and are expected to maintain their dominant position over the forecast period. This is attributed to the rising popularity of VCDs in acute care treatment facilities.
  • Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the presence of unmet demands by the hospitals and rising R&D investment in this region.
  • Some key players operating in this industry include Cardinal Health; Abbott Laboratories; COOK; Medtronic; W L. Gore & Associates; Boston Scientific Corporation; Biotronik GMBH & CO.KG; TZ Medical, Inc.; C. R. Bard, Inc.; ST. JUDE MEDICAL; Cardiva Medical, Inc.; Merit Medical Systems, Inc.; ESSENTIAL MEDICAL, INC; and Scion BioMedical.
  • This market is expected to witness lucrative growth owing to high level of competitive rivalry, which translates to high revenue generation in this sector. These prominent players are opting for different strategies to boost their status in this market. Companies are involved in developing novel VCDs and in turn broaden their product portfolios. Acquisition and collaboration with small companies in order to enhance presence is also expected to propel growth in this vertical.
  • For instance, in October 2015, Cardinal Health acquired Johnson & Johnson’s Cordis business. Cordis is a leader in manufacturing and marketing of cardiology and endovascular devices. This acquisition was intended to expand Cardinal’s VCD product catalog to reinforce its status in the market.
  • North America dominated the market in 2015, with over 33% of total revenue. The presence of key players in this region, which are primarily involved in marketing and development of innovative VCDs, to facilitate cardiac surgeries can be attributed to the largest share of North America. Demand of products for monitoring of coronary artery disease is also expected to drive growth.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented vascular closure devices market on the basis of product, end use, and region:

Global Vascular Closure Devices Outlook, by Product (Revenue, USD Million, 2013 – 2024)

  • Active Approximators
    • Suture-based Devices
    • Clip-based Devices
  • Passive Approximators
    • Collagen Plugs
    • Sealant- or Gel-based Devices
    • Compression-Assist Devices
  • External Hemostatic Devices

Global Vascular Closure Devices Outlook, by End Use (Revenue, USD Million, 2013 – 2024)

  • Acute Care Facilities
  • Hospitals
  • Clinics

Global Vascular Closure Devices Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
    • US.
    • Canada
  • Europe
    • Germany
    • UK
  • Asia Pacific
    • China
    • Japan
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Chile
    • Colombia
    • Peru
    • Venezuela
    • Ecuador
    • Panama
    • Costa Rica
  • MEA
    • South Africa

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-vascular-closure-device-vcd-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Vein Illuminator Market Size, Share, Trend, Global Industry Report from 2013 To 2024

The global Vein Illuminator Market is expected to reach USD 358.5 million by 2024, according to a new report published by Grand View Research, Inc. The vein illuminator market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors contributing towards the growth of the market are the growing aging population and the efforts channelized towards improving patient satisfaction. Additionally, factors, such as the demand for technologically advanced medical equipment and the rising research and practical applications are expected to be opportunistic for the industry growth. However, the prevalence of traditional methods owing to the high costs of the vein illuminator devices is likely to hinder the growth of the market in the near future.

vein-illuminator-market

The vein illuminator market is segmented on the basis of technology, application, end-user, and region. Based on technology, the market is further categorized into transillumination, infrared technology, and ultrasound. The near-infrared illumination technology is estimated to be the largest shareholder due to its ability to penetrate deep into the tissue, which makes it possible to visualize the vessels clearly.

On the basis of application, the market is segmented into intravenous access and blood draw. The end-user segment comprises hospitals, rehabilitation facilities, blood donation camps, and academic institutions. The market for hospitals is expected to grow rapidly during the forecast period due to a surge in the demand for technologically advanced medical equipment. The market is also categorized into North America, Europe, Asia Pacific, MEA, and Latin America.

Browse Full Research Report on Vein Illuminator Market: http://www.grandviewresearch.com/industry-analysis/vein-illuminator-market

Further key findings from the study suggest:

  • In terms of market share, the North America vein illuminator market is expected to hold majority of the share in 2016. Factors resulting in the growth of this industry are the steady preference for highly-advanced medical devices by hospitals as well as the presence of several medical device manufacturing companies in the region.
  • The infrared illumination technology is estimated to lead the industry due to its deep penetration capability into thick tissues tohighlight the presence of vessels with increased clarity. Based on application, the segment for intravenous access is estimated to be the largest shareholder, followed by the blood draw segment.
  • The vein illuminator industry comprises several local as well as global players. Some prominent players in this industry include Accuvein, Inc., Christie Medical Holdings, Inc., Infrared Imaging Systems, Inc., Translite, LLC, and Venoscope, LLC,among others. In order to hold a major share in the industry, the companies are adopting both organic as well as inorganic strategies. The major strategies adopted by the companies are new product development, mergers, collaborations, partnerships, geographical expansions, and acquisitions.
  • The companies are also focusing on research and development activities in order to enhance their product portfolio. For instance, in September 2015, Accuvein, Inc., declared its 26thpatent, which was issued by the United States Patent and Trademark office for their vein visualization system.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the vein illuminator market on the basis of technology, application, and end-user application:

Vein Illuminator Technology Outlook (Revenue, USD Million, 2013 – 2024)

  • Transillumination
  • Infrared technology
  • Others

Vein Illuminator Application Outlook (Revenue, USD Million, 2013 – 2024)

  • Intravenous access
  • Blood draw
  • Others

Vein Illuminator End-user Outlook (Revenue, USD Million, 2013 – 2024)

  • Hospitals
  • Blood donation camps
  • Academic institutions
  • Others

Vein Illuminator Regional Outlook (Revenue, USD Million, 2013 – 2024)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • MEA

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-vein-illuminator-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transparent Ceramics Market was valued at USD 178.5 Million in 2015 and Is Expected To Witness Grow Swiftly

The global Transparent Ceramics Market is expected to reach USD 1.08 billion by 2024, according to a new report by Grand View Research, Inc. Increasing demand for the product in various industries including electronics, aviation, and healthcare as a substitute for existing glass technologies in numerous function such as armors, optical fibers, domes(infrared) & lasers is expected to drive demand. Expansion of these end-use industries is predicted to fuel the industry growth further over the next eight years.

transparent-ceramics-market.png

Rising focus on utilizing cutting & laser tools across the world, on account of rapid industrialization and turnaround of the manufacturing sector, is expected to propel growth. The increase of the ceramics industry is also driving expansion over the next eight years.

The global market for transparent ceramics was valued at USD 178.5 million in 2015 and is expected to witness growth over the forecast period on account of rising manufacturing facilities in emerging markets of Asia Pacific such as India and China coupled with increasing expenditure on defense on improved & enhanced technology. Growing need from end-user industries such as chemical & mechanical industries, instrumentation & sensor and optics & optoelectronics is expected to stimulate expansion.

Browse Full Research Report on Transparent Ceramics Market: http://www.grandviewresearch.com/industry-analysis/transparent-ceramics-market

Further key findings from the report suggest:

  • Transparent ceramics blankets are suitable for high-temperature procedures. Lightweight, low thermal conductivity & heat storage, soaring temperature stability, outstanding handling power & fire protection, corrosion and thermal shock resistance and resistance are some of the properties owing to which blankets are preferred. The market is likely to witness growth at a CAGR of 21.8% from 2016 to 2024.
  • The transparent ceramics demand in optic & optoelectronics was USD 61.4 million in 2015. These products are used in medical & healthcare industries. Advancements in the healthcare sector across the globe is expected to drive industry development over the forecast period.
  • Asia Pacific contributed to 47.1% of the global market in 2015 and is projected to witness massive expansion in light of augmented government expenditure on the industrial sector and increasing opportunities for FDI in China and India. Rising demand for defense and iron & steel on account of rapid industrialization is expected to drive growth.
  • The Middle East & Africa is expected to observe considerable gains at a CAGR of 20.9% from 2016 to 2024. Increasing expenditure on aviation & defense by governments in the Middle East is expected to propel growth.
  • Key industry players include Surmet Corporation, CoorsTek, Murata Manufacturing Co. Ltd., ETEC, and Koito Manufacturing. These companies focus on research for product development to enhance their portfolio. Also, numerous research institutes are also focusing on R&D for increasing the application scope of transparent ceramics. For instance, in April 2014, the U.S. Naval Research Laboratory (NRL) developed a method that fabricates nanocrystalline spinel, which is 50% harder than the existing spinel armor materials utilized in military vehicles.

Read Our Blog: http://www.grandviewresearch.com/blogs/advanced-materials

Grand View Research has segmented the global transparent ceramics market on the basis of product, material, application and region:

Product Outlook (Revenue, USD Million; 2016 – 2024)

  • Sapphire
  • Yttrium Aluminum Garnet
  • Aluminum Oxynitride
  • Spinel
  • Others

Material Outlook (Revenue, USD Million; 2016 – 2024)

  • Monocrystalline Transparent Ceramics
  • Polycrystalline Transparent Ceramics
  • Others

Application Outlook (Revenue, USD Million; 2016- 2024)

  • Optics & Optoelectronics
  • Aerospace, Defense & Security
  • Mechanical/Chemical
  • Sensors & Instrumentation
  • Healthcare
  • Consumer
  • Energy
  • Others

Regional Outlook (Revenue, USD Million; 2016 – 2024)

  • North America
    • US.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • Italy
  • Asia Pacific
    • China
    • India
    • Japan
  • Latin America
    • Brazil
    • Chile
  • MEA

Access Press Release of this Report: http://www.grandviewresearch.com/press-release/global-transparent-ceramics-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Rising demand for Organ Transplantation is primarily fueling the demand for transplant diagnostics Market

The global Transplant Diagnostic Market is expected to reach USD 895.2 million by 2024, according to a new report by Grand View Research Inc. The rising demand for organ transplantation is primarily fueling the demand for transplant diagnostics.

Constant healthcare research and development efforts are resulting in the introduction of technically advanced treatments, such as stem cell therapy and organ transplants. As a result, the adoption of these highly-advanced organ transplantation techniques is creating the demand for transplant diagnostics as they reduce the risk of infections and minimize the chances of an immune response through pre-operative assessments including histocompatibility tests, such as Human Leukocyte Antigen (HLA) typing, which determines donor-receiver organ or tissue compatibility prior to organ transplants.

transparent-ceramics-market

In addition, pertinent organizations are supporting research and development initiatives in the field of organ transplant through grants and funding. As a result, innovative and advanced diagnostic tools are frequently entering into the market. On the other hand, high cost of the diagnostic tests is one of the major factors hindering the growth of the market.

Geographically, the market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa (MEA). North America and Europe together accounted for the largest market share in 2015. Developed economies and well-established healthcare infrastructure coupled with the presence of a highly developed research infrastructure are accelerating the adoption of organ and tissue transplant therapies in Europe and North America. As a consequence, the demand for transplant diagnostics is high in North America and Europe.

Wide adoption of HLA typing owing to its ability to determine organ compatibility between the donor and the receiver preceding organ transplants and to predict potential perioperative immunological complications is driving the growth of the molecular assay market in North America and Europe.

Asia Pacific is expected to show the fastest growth rate during the forecast period owing to the booming medical tourism in countries, such as India. Availability of advanced healthcare infrastructure and skilled professionals at alower costare anticipated to attract patients worldwide to this region for transplant procedures.

In addition, the presence of highly advanced healthcare infrastructure and the ongoing government initiatives to improve healthcare facilities in the country are collectively anticipated to boost the market growth in Japan during the forecast period. As a result, the Asia Pacific market is anticipated to reach USD 216.6 million in 2024.

Browse Full Research Report on Transplant Diagnostic Market: http://www.grandviewresearch.com/industry-analysis/transplant-diagnostic-market

Further key findings from the study suggest:

  • The PCR-based molecular assay captured the largest share of the overall market in 2015. The large market share was mainly attributed to the extensive adoption of the PCR  technique in HLA typing.
  • The sequencing-based typing segment is anticipated to witness significant growth rate from 2016 to 2024. The escalation in the adoption of next generation sequencing (NGS) is the major factor expected to drive the growth of this segment during the forecast period.
  • The integration of sequencing with serological typing enhances diagnostic outcomes and, hence is expected to augment the growth of the sequencing segment during the forecast period
  • The reagents and consumables segment accounted for the largest market share in 2015. This large share is mainly attributed to the repeat purchase of these products.
  • North America captured the largest market share of around 38% in 2015 and is expected to maintain its dominance throughout the forecast period. Well-established research infrastructure, the increasing healthcare expenditure, high adoption rate ofthe advanced diagnostic techniques, and the growing R&D activities are some of the factors supporting the growth of the market in the region.
  • Asia Pacific is expected to witness significant growth during the forecast period owing to the expanding research opportunities, the increasing health care expenditure, and the rising awareness of organ donation in the region.
  • The booming medical tourism industry offers further growth opportunities for the market in Asia Pacific
  • Some major players in this market include Thermo Fisher Scientific, Inc., Illumina, Inc., F.Hoffmann La-Roche AG. Abbott Laboratories, Inc.,Qiagen N.V., Immucor Transplant Diagnostics, Inc., Bio-Rad Laboratories, Inc., Affymetrix, Inc.,  and Omixon Ltd.

Read Our Blog: http://www.grandviewresearch.com/blogs/healthcare

Grand View Research has segmented the Transplant Diagnostic Market on the basis of technology, product, and geography. 

Transplant Diagnostic Market by Technology, 2013 – 2024 (USD Million)      

  • Molecular Assays
    • PCR-Based Molecular Assays
    • Sequencing-Based Molecular Assays
  • Non-Molecular Assays
    • Serological Assays
    • Mixed Lymphocyte Culture (MLC) Assays

Transplant Diagnostic Market by Product, 2013 – 2024 (USD Million)       

  • Reagents and Consumables
  • Instruments
  • Software and Services

Transplant Diagnostics Market, by Region, 2013- 2024 (USD Million)

  • North America
    • US. Transplant Diagnostics Market by Product Type
    • Canada Transplant Diagnostics Market by Product Type
    • US.Transplant Diagnostics Market by Technology Type
    • Canada Transplant Diagnostics Market by Technology
  • Europe
    • Germany Transplant Diagnostics Market by Product Type
    • France Transplant Diagnostics Market by Product Type
    • Germany Transplant Diagnostics Market by Technology
    • France Transplant Diagnostics Market by Technology
  • Asia Pacific
    • China Transplant Diagnostics Market by Product Type
    • India Transplant Diagnostics Market by Product Type
    • China Transplant Diagnostics Market by Technology
    • India Transplant Diagnostics Market by Technology
  • Latin America
    • Brazil Transplant Diagnostics Market by Product Type
    • Mexico Transplant Diagnostics Market by Product Type
    • Brazil Transplant Diagnostics Market by Technology
    • Mexico Transplant Diagnostics Marketby Technology
  • MEA
    • South Africa Transplant Diagnostics Market by Product Type
    • South Africa Transplant Diagnostics Market by Technology

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com